[1]
2021. Alectinib and lorlatinib function by modulating EMT-related proteins and MMPs in NSCLC metastasis. Biomolecules and Biomedicine. 21, 3 (Jun. 2021), 331–338. DOI:https://doi.org/10.17305/bjbms.2020.5066.